Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis
Topic To provide updated estimates on the global prevalence and number of people with
diabetic retinopathy (DR) through 2045. Clinical Relevance The International Diabetes …
diabetic retinopathy (DR) through 2045. Clinical Relevance The International Diabetes …
An update on the epidemiology of type 2 diabetes: a global perspective
MG Tinajero, VS Malik - Endocrinology and Metabolism Clinics, 2021 - endo.theclinics.com
Type 2 diabetes (T2D) is a chronic health condition that has reached alarming rates across
the globe. A little more than 2 decades ago, the International Diabetes Federation (IDF) …
the globe. A little more than 2 decades ago, the International Diabetes Federation (IDF) …
Prevalence of chronic kidney disease in Asia: a systematic review and analysis
T Liyanage, T Toyama, C Hockham, T Ninomiya… - BMJ global …, 2022 - gh.bmj.com
Introduction The burden of chronic kidney disease (CKD) is growing rapidly around the
world. However, there is limited information on the overall regional prevalence of CKD, as …
world. However, there is limited information on the overall regional prevalence of CKD, as …
[HTML][HTML] Diabetic retinopathy: current understanding, mechanisms, and treatment strategies
Diabetic retinopathy (DR) causes significant visual loss on a global scale. Treatments for the
vision-threatening complications of diabetic macular edema (DME) and proliferative diabetic …
vision-threatening complications of diabetic macular edema (DME) and proliferative diabetic …
[HTML][HTML] Prevalence and trends of metabolic syndrome among adults in the asia-pacific region: a systematic review
Abstract Background The Asia-Pacific region is home to nearly half of the world's population.
The region has seen a recent rapid increase in the prevalence of obesity, type-2 diabetes …
The region has seen a recent rapid increase in the prevalence of obesity, type-2 diabetes …
Cardiovascular events associated with SGLT-2 inhibitors versus other glucose-lowering drugs: the CVD-REAL 2 study
Background Randomized trials demonstrated a lower risk of cardiovascular (CV) events with
sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes (T2D) at …
sodium-glucose cotransporter-2 inhibitors (SGLT-2i) in patients with type 2 diabetes (T2D) at …
Ambient air pollution and diabetes: a systematic review and meta-analysis
BY Yang, S Fan, E Thiering, J Seissler, D Nowak… - Environmental …, 2020 - Elsevier
Background Air pollutants are suggested to be related to type 2 diabetes (T2D). Since
several high quality papers on air pollutants and T2D have been published beyond the last …
several high quality papers on air pollutants and T2D have been published beyond the last …
[HTML][HTML] Epidemiology of diabetes and diabetic complications in China
RCW Ma - Diabetologia, 2018 - Springer
Abstract The People's Republic of China (herein referred to as China) has witnessed one of
the most dramatic rises in diabetes prevalence anywhere in the world. The latest …
the most dramatic rises in diabetes prevalence anywhere in the world. The latest …
Asian perspective on NAFLD-associated HCC
Recent data suggest that non-alcoholic fatty liver disease (NAFLD) has become a major
public health problem in Asia, with an updated population prevalence of 34%. In parallel …
public health problem in Asia, with an updated population prevalence of 34%. In parallel …
Hyperglycemia during pregnancy and long-term offspring outcomes
ME Bianco, JL Josefson - Current diabetes reports, 2019 - Springer
Abstract Purpose of Review This review will focus on the long-term outcomes in offspring
exposed to in utero hyperglycemia and gestational diabetes (GDM), including obesity …
exposed to in utero hyperglycemia and gestational diabetes (GDM), including obesity …